Prulifloxacin versus Levofloxacin in the Treatment of Respiratory and Urinary Tract Infections: A Multicentre, Double-Blind, Randomized Controlled Clinical Trial

Background: Prulifloxacin is a promising fluoroquinolone antibiotic. A multicentre, double-blind, randomized clinical study was designed to evaluate its efficacy and safety compared to that of levofloxacin for the treatment of respiratory and urinary infections of Chinese patients. Methods: A total...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chemotherapy (Basel) 2012-01, Vol.58 (3), p.249-256
Hauptverfasser:	Chen, Yongchuan, Yang, Heping, Lu, Gensheng, Wu, Xiongfei, Huang, Wenxiang, Wu, Yamei, Lv, Xiaoju, Wu, Guoming, Zhang, Genfu, Li, Qiang, Sun, Yinghao
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anti-Bacterial Agents - therapeutic use Antibiotics Bacterial infections Clinical Study Dioxolanes - pharmacology Dioxolanes - therapeutic use Disk Diffusion Antimicrobial Tests Double-Blind Method Female Fluoroquinolones - pharmacology Fluoroquinolones - therapeutic use Gram-Negative Bacteria - drug effects Gram-Positive Bacteria - drug effects Humans Levofloxacin Male Middle Aged Ofloxacin - pharmacology Ofloxacin - therapeutic use Piperazines - pharmacology Piperazines - therapeutic use Respiratory diseases Respiratory Tract Infections - drug therapy Treatment Outcome Urinary tract diseases Urinary Tract Infections - drug therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!